Clinical Trial Update: Regorafenib in Frail and/or Unfit for Chemotherapy Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

This update notes the completion of a Phase 2 trial evaluating regorafenib in patients with metastatic colorectal cancer who are frail or unfit for standard che…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Regorafenib (Stivarga) (regorafenib)

Snippet

Sponsor: Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | Conditions: Colorectal Neoplasms, Metastatic Disease | Phase 2 | Status: COMPLETED